Literature DB >> 12112670

Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling.

Jianwen Zhang1, Chi-Hao Luan, Kuo-Chen Chou, Gail V W Johnson.   

Abstract

Cyclin dependent kinase (Cdk) 5, an atypical member of the Cdk family, plays a fundamental role in the development of the nervous system, and may also be involved in the pathogenesis of certain neurodegenerative diseases. Further, Cdk5 is activated by the specific regulatory proteins p39, p35, or p25 rather than cyclins, and in contrast to other members of the Cdk family is not involved in the progression of the cell cycle. A three-dimensional computer model of Cdk5-p25-ATP has been generated previously [Chou et al., Biochem Biophys Res Commun 1999;259:420-428], providing a structural basis for the study of the mechanisms of Cdk5 activation. To assess the predicted ATP and p25 binding domains at the N-terminal of Cdk5, two mutants of Cdk5 were prepared in which amino acids 9-15 (Delta9-15) or 9-47 (Delta9-47) were deleted. The results of these studies clearly demonstrate that an N-terminal loop and the PSSALRE helix are indispensable for Cdk5-p25 interactions, and amino acids 9-15 are necessary for ATP binding but are not involved in Cdk5-p25 interactions. Predicted models of Delta9-15 Cdk5 and Delta9-47 Cdk5 were generated, and were used to interpret the experimental data. The experimental and molecular modeling results confirm and extend specific aspects of the original predicted computer model, and may provide useful information for the design of highly selective inhibitors of Cdk5, which could be used in the treatment of certain neurodegenerative conditions. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112670     DOI: 10.1002/prot.10173

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  10 in total

1.  Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.

Authors:  S M Fayaz; G K Rajanikant
Journal:  Mol Divers       Date:  2015-07-14       Impact factor: 2.943

2.  Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.

Authors:  Jiansong Fang; Ranyao Yang; Li Gao; Shengqian Yang; Xiaocong Pang; Chao Li; Yangyang He; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2014-12-16       Impact factor: 2.943

3.  Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach.

Authors:  Ying Ma; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

4.  Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase.

Authors:  Qishi Du; Shuqing Wang; Dongqing Wei; Suzanne Sirois; Kuo-Chen Chou
Journal:  Anal Biochem       Date:  2005-02-15       Impact factor: 3.365

5.  Combining evolutionary information extracted from frequency profiles with sequence-based kernels for protein remote homology detection.

Authors:  Bin Liu; Deyuan Zhang; Ruifeng Xu; Jinghao Xu; Xiaolong Wang; Qingcai Chen; Qiwen Dong; Kuo-Chen Chou
Journal:  Bioinformatics       Date:  2013-12-05       Impact factor: 6.937

6.  Designing, docking and molecular dynamics simulation studies of novel cloperastine analogues as anti-allergic agents: homology modeling and active site prediction for the human histamine H1 receptor.

Authors:  Jayasimha Rayalu Daddam; Basha Sreenivasulu; Kotha Peddanna; Katike Umamahesh
Journal:  RSC Adv       Date:  2020-01-29       Impact factor: 4.036

7.  Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations.

Authors:  Sundarapandian Thangapandian; Shalini John; Prettina Lazar; Sun Choi; Keun Woo Lee
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

8.  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

Authors:  Kuo-Chen Chou; Dong-Qing Wei; Wei-Zhu Zhong
Journal:  Biochem Biophys Res Commun       Date:  2003-08-15       Impact factor: 3.575

9.  Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.

Authors:  Qi-Shi Du; Shu-Qing Wang; Yu Zhu; Dong-Qing Wei; Hong Guo; Suzanne Sirois; Kuo-Chen Chou
Journal:  Peptides       Date:  2004-11       Impact factor: 3.750

10.  A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β.

Authors:  H Pradeep; G K Rajanikant
Journal:  Mol Divers       Date:  2012-08-24       Impact factor: 2.943

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.